Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Toan C. Ong"'
Autor:
Ruth Link-Gelles, Matthew E. Levy, Manjusha Gaglani, Stephanie A. Irving, Melissa Stockwell, Kristin Dascomb, Malini B. DeSilva, Sarah E. Reese, I-Chia Liao, Toan C. Ong, Shaun J. Grannis, Charlene McEvoy, Palak Patel, Nicola P. Klein, Emily Hartmann, Edward Stenehjem, Karthik Natarajan, Allison L. Naleway, Kempapura Murthy, Suchitra Rao, Brian E. Dixon, Anupam B. Kharbanda, Akintunde Akinseye, Monica Dickerson, Ned Lewis, Nancy Grisel, Jungmi Han, Michelle A. Barron, William F. Fadel, Margaret M. Dunne, Kristin Goddard, Julie Arndorfer, Deepika Konatham, Nimish R. Valvi, J. C. Currey, Bruce Fireman, Chandni Raiyani, Ousseny Zerbo, Chantel Sloan-Aagard, Sarah W. Ball, Mark G. Thompson, Mark W. Tenforde
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:931-939
The Omicron variant (B.1.1.529) of SARS-CoV-2, the virus that causes COVID-19, was first identified in the United States in November 2021, with the BA.1 sublineage (including BA.1.1) causing the largest surge in COVID-19 cases to date. Omicron sublin
Autor:
Karthik Natarajan, Namrata Prasad, Kristin Dascomb, Stephanie A. Irving, Duck-Hye Yang, Manjusha Gaglani, Nicola P. Klein, Malini B. DeSilva, Toan C. Ong, Shaun J. Grannis, Edward Stenehjem, Ruth Link-Gelles, Elizabeth A. Rowley, Allison L. Naleway, Jungmi Han, Chandni Raiyani, Gabriela Vazquez Benitez, Suchitra Rao, Ned Lewis, William F. Fadel, Nancy Grisel, Eric P. Griggs, Margaret M. Dunne, Melissa S. Stockwell, Mufaddal Mamawala, Charlene McEvoy, Michelle A. Barron, Kristin Goddard, Nimish R. Valvi, Julie Arndorfer, Palak Patel, Patrick K Mitchell, Michael Smith, Anupam B. Kharbanda, Bruce Fireman, Peter J. Embi, Monica Dickerson, Jonathan M. Davis, Ousseny Zerbo, Alexandra F. Dalton, Mehiret H. Wondimu, Eduardo Azziz-Baumgartner, Catherine H. Bozio, Sue Reynolds, Jill Ferdinands, Jeremiah Williams, Stephanie J. Schrag, Jennifer R. Verani, Sarah Ball, Mark G. Thompson, Brian E. Dixon
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:495-502
CDC recommends that all persons aged ≥18 years receive a single COVID-19 vaccine booster dose ≥2 months after receipt of an Ad.26.COV2.S (Janssen [JohnsonJohnson]) adenovirus vector-based primary series vaccine; a heterologous COVID-19 mRNA vacci
Autor:
Rachael M. Porter, I-Chia Liao, Palak Patel, Nimish R Valvi, Duck-Hye Yang, Sue Reynolds, Ned Lewis, Patrick K. Mitchell, Catherine H Bozio, Malini B. DeSilva, Sarah Ball, Manjusha Gaglani, Brian E. Dixon, Kristin Goddard, Toan C Ong, Edward Stenehjem, Kristen A Butterfield, Stephanie A. Irving, Charlene McEvoy, Bruce Fireman, Anupam B Kharbanda, Andrea Steffens, Rebecca J Birch, Nancy Grisel, Peter J Embi, Meredith McMorrow, Julie Arndorfer, Shaun J. Grannis, Jennifer R. Verani, Natalie Olson, Kempapura Murthy, Jill M. Ferdinands, Elizabeth A Rowley, Alicia M. Fry, Jungmi Han, Lenee Blanton, Mark G. Thompson, Eric P Griggs, Chandni Raiyani, Kristin Dascomb, William F. Fadel, Suchitra Rao, Matthew E Levy, Karthik Natarajan, Michelle A Barron, Nicola P. Klein, Eduardo Azziz-Baumgartner, Sarah E Reese, Ousseny Zerbo, Stephanie J. Schrag, Monica Dickerson, Allison L. Naleway, Jeremiah Williams
Publikováno v:
Morbidity and Mortality Weekly Report
Previous infection with SARS-CoV-2 (the virus that causes COVID-19) or COVID-19 vaccination can provide immunity and protection from subsequent SARS-CoV-2 infection and illness. CDC used data from the VISION Network* to examine hospitalizations in ad
Autor:
Ned Lewis, Shaun J. Grannis, Stephanie A. Irving, Eduardo Azziz-Baumgartner, Rachael M. Porter, Sarah Ball, Eric P. Griggs, Yan Zhuang, Matthew E Levy, Kristin Dascomb, Edward Stenehjem, Suchitra Rao, Maria Demarco, Jennifer R. Verani, Pat Shifflett, Ousseny Zerbo, Kristin Goddard, Malini B. DeSilva, Natalie Olson, Stephanie J. Schrag, Manjusha Gaglani, Catherine H Bozio, J.A Arndorfer, Lenee Blanton, Bruce Fireman, Allison L. Naleway, Mark G. Thompson, Karthik Natarajan, Michelle A. Barron, Nimish R. Valvi, Elizabeth A Rowley, Toan C. Ong, Nicola P. Klein, Nancy Grisel, Sue Reynolds, William F. Fadel, Palak Patel, Alicia M Fry, Jill M. Ferdinands, Brian E. Dixon, Jungmi Han, Elyse O. Kharbanda, Rebecca J. Birch, Andrea Steffens
Publikováno v:
The New England Journal of Medicine
Background There are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect to hospitalization, admission to an intensive care unit (ICU), or am
Autor:
David J. Douin, Adane F. Wogu, Laurel E. Beaty, Nichole E. Carlson, Tellen D. Bennett, Neil R. Aggarwal, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey Steele, Jennifer L. Peers, Kyle C. Molina, Matthew K. Wynia, Adit A. Ginde
Publikováno v:
BMC Infectious Diseases. 22
Background Neutralizing monoclonal antibodies (mAbs) are highly effective in reducing hospitalization and mortality among early symptomatic COVID-19 patients in clinical trials and real-world data. While resistance to some mAbs has since emerged amon
Autor:
Amadea Britton, Peter J. Embi, Matthew E. Levy, Manjusha Gaglani, Malini B. DeSilva, Brian E. Dixon, Kristin Dascomb, Palak Patel, Kristin E. Schrader, Nicola P. Klein, Toan C. Ong, Karthik Natarajan, Emily Hartmann, Anupam B. Kharbanda, Stephanie A. Irving, Monica Dickerson, Margaret M. Dunne, Chandni Raiyani, Shaun J. Grannis, Edward Stenehjem, Ousseny Zerbo, Suchitra Rao, Jungmi Han, Chantel Sloan-Aagard, Eric P. Griggs, Zachary A. Weber, Kempapura Murthy, William F. Fadel, Nancy Grisel, Charlene McEvoy, Ned Lewis, Michelle A. Barron, Juan Nanez, Sarah E. Reese, Mufaddal Mamawala, Nimish R. Valvi, Julie Arndorfer, Kristin Goddard, Duck-Hye Yang, Bruce Fireman, Sarah W. Ball, Ruth Link-Gelles, Allison L. Naleway, Mark W. Tenforde
Publikováno v:
MMWR. Morbidity and mortality weekly report. 71(42)
Persons with moderate-to-severe immunocompromising conditions might have reduced protection after COVID-19 vaccination, compared with persons without immunocompromising conditions (1-3). On August 13, 2021, the Advisory Committee on Immunization Prac
Autor:
Jill M Ferdinands, Suchitra Rao, Brian E Dixon, Patrick K Mitchell, Malini B DeSilva, Stephanie A Irving, Ned Lewis, Karthik Natarajan, Edward Stenehjem, Shaun J Grannis, Jungmi Han, Charlene McEvoy, Toan C Ong, Allison L Naleway, Sarah E Reese, Peter J Embi, Kristin Dascomb, Nicola P Klein, Eric P Griggs, I-Chia Liao, Duck-Hye Yang, William F Fadel, Nancy Grisel, Kristin Goddard, Palak Patel, Kempapura Murthy, Rebecca Birch, Nimish R Valvi, Julie Arndorfer, Ousseny Zerbo, Monica Dickerson, Chandni Raiyani, Jeremiah Williams, Catherine H Bozio, Lenee Blanton, Ruth Link-Gelles, Michelle A Barron, Manjusha Gaglani, Mark G Thompson, Bruce Fireman
Publikováno v:
BMJ (Clinical research ed.). 379
Objective To estimate the effectiveness of mRNA vaccines against moderate and severe covid-19 in adults by time since second, third, or fourth doses, and by age and immunocompromised status. Design Test negative case-control study. Setting Hospitals,
Autor:
Shaun J. Grannis, Mark G. Thompson, Edward Stenehjem, Allison L. Naleway, Karthik Natarajan, Nicola P. Klein, Toan C. Ong, Malini B. DeSilva, Elizabeth A Rowley
Publikováno v:
Morbidity and Mortality Weekly Report
Data on COVID-19 vaccine effectiveness (VE) since the B.1.617.2 (Delta) variant of SARS-CoV-2, the virus that causes COVID-19, became the predominant circulating strain in the United States are limited (1-3). CDC used the VISION Network* to examine m
Autor:
Neil R Aggarwal, Laurel E Beaty, Tellen D Bennett, Nichole E Carlson, Christopher B Davis, Bethany M Kwan, David A Mayer, Toan C Ong, Seth Russell, Jeffrey Steele, Adane F Wogu, Matthew K Wynia, Richard D Zane, Adit A Ginde
Publikováno v:
J Infect Dis
medRxiv
medRxiv
Neutralizing monoclonal antibodies (mAbs) are authorized for early symptomatic COVID-19 patients. Whether mAbs are effective against the SARS-CoV-2 Delta variant, among vaccinated patients, or for prevention of mortality remains unknown.To evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87111a410f8822f0002ec1b5d7c91792
https://europepmc.org/articles/PMC10205600/
https://europepmc.org/articles/PMC10205600/
Autor:
Nicola P, Klein, Melissa S, Stockwell, Maria, Demarco, Manjusha, Gaglani, Anupam B, Kharbanda, Stephanie A, Irving, Suchitra, Rao, Shaun J, Grannis, Kristin, Dascomb, Kempapura, Murthy, Elizabeth A, Rowley, Alexandra F, Dalton, Malini B, DeSilva, Brian E, Dixon, Karthik, Natarajan, Edward, Stenehjem, Allison L, Naleway, Ned, Lewis, Toan C, Ong, Palak, Patel, Deepika, Konatham, Peter J, Embi, Sarah E, Reese, Jungmi, Han, Nancy, Grisel, Kristin, Goddard, Michelle A, Barron, Monica, Dickerson, I-Chia, Liao, William F, Fadel, Duck-Hye, Yang, Julie, Arndorfer, Bruce, Fireman, Eric P, Griggs, Nimish R, Valvi, Carly, Hallowell, Ousseny, Zerbo, Sue, Reynolds, Jill, Ferdinands, Mehiret H, Wondimu, Jeremiah, Williams, Catherine H, Bozio, Ruth, Link-Gelles, Eduardo, Azziz-Baumgartner, Stephanie J, Schrag, Mark G, Thompson, Jennifer R, Verani
Publikováno v:
MMWR. Morbidity and mortality weekly report. 71(9)
The efficacy of the BNT162b2 (Pfizer-BioNTech) vaccine against laboratory-confirmed COVID-19 exceeded 90% in clinical trials that included children and adolescents aged 5-11, 12-15, and 16-17 years (1-3). Limited real-world data on 2-dose mRNA vaccin